FDA 483 - FUJIFILM Diosynth Biotechnologies Denmark ApS

Biogen (Denmark) Manufacturing ApS, a drug substance manufacturer in Hillerod, Denmark, was cited for inadequate laboratory testing procedures during an FDA inspection. The firm lacked defined time limits for performing tests after in-process sample collection, specifically for endotoxin samples. This included a lack of studies to support storage conditions for these samples.